We are live on ! Find out more
PCM

Palouse Capital Management Portfolio holdings

AUM $160M
1-Year Est. Return 36.15%
This Fund
S&P 500
This Quarter Est. Return
-12.53%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$202M
AUM Growth
-$25.5M
Cap. Flow
+$3.24M
Cap. Flow %
1.6%
Top 10 Hldgs %
26.95%
Holding
105
New
5
Increased
30
Reduced
44
Closed
24

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$5.28M
2
UPS icon
United Parcel Service
UPS
+$4.03M
3
CSCO icon
Cisco
CSCO
+$3.53M
4
STT icon
State Street
STT
+$3.3M
5
GLW icon
Corning
GLW
+$3.28M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$3.24M
2
CAH icon
Cardinal Health
CAH
+$3.1M
3
GILD icon
Gilead Sciences
GILD
+$3.06M
4
PM icon
Philip Morris
PM
+$2.07M
5
NEM icon
Newmont
NEM
+$1.75M

Sector Composition

Rank Sector Weight
1 Technology 19.92%
2 Financials 16.81%
3 Healthcare 14.24%
4 Consumer Discretionary 9.42%
5 Consumer Staples 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAL icon
101
Western Alliance Bancorporation
WAL
$8.87B
-2,436
Closed -$202K
WBS icon
102
Webster Financial
WBS
$12.8B
-3,657
Closed -$205K
WRK
103
DELISTED
WestRock Company
WRK
-5,602
Closed -$263K
PACW
104
DELISTED
PacWest Bancorp
PACW
-6,340
Closed -$273K
VMW
105
DELISTED
VMware, Inc
VMW
-8,550
Closed -$974K

Similar funds

Palouse Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Palouse Capital Management held 105 positions worth $202M, down 11% from $227M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Palouse Capital Management's Q2 2022 filing shows 5 new, 30 increased, 44 reduced and 24 closed positions. Its largest new stake was Target: 27,549 shares worth $3.89M. The largest sale was Merck, an estimated $3.24M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Palouse Capital Management's largest Q2 2022 buy was Target: 27,549 shares worth $3.89M.
  • Palouse Capital Management added most to Ericsson in Q2 2022, an estimated $3.07M increase.
  • Palouse Capital Management's biggest Q2 2022 reduction was Newmont, cutting an estimated $1.75M.
  • Palouse Capital Management fully exited Merck in Q2 2022, selling an estimated $3.24M.
  • Palouse Capital Management's ten largest holdings make up 27% of its $202M portfolio in Q2 2022.
  • Palouse Capital Management opened 5 new positions and closed 24 in Q2 2022.
  • Palouse Capital Management's portfolio value fell 11% quarter-over-quarter to $202M.

Based on Palouse Capital Management's 13F filing for Q2 2022, filed 28 Jul 2022.